Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) EBT Margin (2016 - 2025)

Avanos Medical (AVNS) has disclosed EBT Margin for 13 consecutive years, with 0.66% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 23479.0% to 0.66% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 9.44% through Dec 2025, up 4920.0% year-over-year, with the annual reading at 9.44% for FY2025, 4920.0% up from the prior year.
  • EBT Margin hit 0.66% in Q4 2025 for Avanos Medical, up from 0.67% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 7.87% in Q4 2022 to a low of 234.13% in Q4 2024.
  • Historically, EBT Margin has averaged 15.99% across 5 years, with a median of 0.78% in 2025.
  • Biggest five-year swings in EBT Margin: plummeted -23927bps in 2024 and later surged 23479bps in 2025.
  • Year by year, EBT Margin stood at 64.53% in 2021, then soared by 112bps to 7.87% in 2022, then tumbled by -35bps to 5.14% in 2023, then plummeted by -4659bps to 234.13% in 2024, then skyrocketed by 100bps to 0.66% in 2025.
  • Business Quant data shows EBT Margin for AVNS at 0.66% in Q4 2025, 0.67% in Q3 2025, and 43.37% in Q2 2025.